Buprenorphine and Leuprolide: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Leuprolide
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine (a pain and addiction medicine) and leuprolide (used for prostate cancer, endometriosis, and some other conditions) can each affect your heart's electrical rhythm. Specifically, they may lengthen a part of the heartbeat called the QT interval. When two medicines that do this are taken together, the effect can add up, which in rare cases could lead to an irregular heartbeat.
Please know this concern is mostly theoretical, meaning it is based on how the drugs work rather than lots of real-world reports. Many people use both safely. Keep taking both as prescribed, and let your care team know if you feel dizzy, faint, or notice a racing or fluttering heartbeat. They can watch this closely for you.
Effect: Additive QT interval prolongation with concurrent buprenorphine and leuprolide.
Mechanism: Pharmacodynamic additivity on cardiac repolarization; neither agent is enzymatically activated in a way that alters direction. Both carry independent QT-prolonging signals.
- Direction: Increased risk of QTc prolongation / torsades de pointes.
- Onset: Unspecified.
- Evidence: Theoretical; combined risk not quantified.
- Magnitude: Unknown.
Management: Avoid concomitant use where possible. If co-prescribed, assess and correct electrolytes (K+, Mg2+), review other QT-prolonging drugs, and consider baseline and follow-up ECG. Heightened caution with hypokalemia, bradycardia, recent cardioversion, CHF, digitalis therapy, baseline QT prolongation, or long-QT syndrome.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Refrain from using buprenorphine together with agents capable of prolonging the QT interval342. It remains unknown what risk arises when buprenorphine is paired with other QT prolonging drugs. When prescribing buprenorphine to individuals who carry risk factors, including hypokalemia, bradycardia, recent conversion from atrial fibrillation, congestive heart failure, digitalis therapy, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia, these considerations should inform clinical decisions1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Your care team can manage this concern, usually by weighing whether both drugs are truly needed and by monitoring you.
- Keep taking both as prescribed unless your prescriber tells you otherwise.
- Your team may check your ECG and blood levels of potassium and magnesium, since low levels raise the risk.
- Tell your pharmacist about all other medicines you take, as some also affect heart rhythm.
- Mention any history of heart rhythm problems, heart failure, slow heartbeat, or fainting.
Contact your care team promptly if you feel dizzy, faint, or have palpitations.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Buprenorphine and Leuprolide together?
Buprenorphine and leuprolide can each lengthen the QT interval, so together they may add up and raise the risk of an irregular heartbeat. The risk is theoretical, but your care team may prefer to avoid the combination or monitor your heart rhythm and electrolytes. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Buprenorphine and Leuprolide interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Buprenorphine and Leuprolide interaction managed?
Your care team can manage this concern, usually by weighing whether both drugs are truly needed and by monitoring you. Keep taking both as prescribed unless your prescriber tells you otherwise. Your team may check your ECG and blood levels of potassium and magnesium, since low levels raise the risk. Tell your pharmacist about all other medicines you take, as some also affect heart rhythm. Mention… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Buprenorphine or Leuprolide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Leuprolide
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist